Home > Investor Relations

Investor Relations

Quick Links

Financial Disclosures

Un-audited Financial Results quarter ended June 30, 2022
Audited Financial Results for the quarter & year ended March 31, 2022
Unaudited Financial Results quarter ended December 31, 2021
Annual Financials -FY 20-21
Annual Financials -FY 19-20
Annual Financials -FY 18-19

Other Disclosures as per Debt listed Company

Disclosure under Regulation 57(1)
Intimation of Record Date
Newspaper publication of financial results for the quarter and nine months period ended December 31, 2023
Un-audited Financial Results for quarter and nine months ended December 31, 2023
Outcome of Board Meeting- February 13, 2024
Notice of Board Meeting -February13, 2024
Details of the RTA under Regulation 7(1) for the quarter ended December 31, 2023
Investor Grievance Report for the quarter ended December 31, 2023
Details of the CO under Regulation 6(1) for the quarter ended December 31, 2023
Proceedings of EGM - January 3, 2023
Disclosure under Regulation 51
Intimation of EGM - January 3, 2023
Notice of Board Meeting - January 3, 2023
Proceedings of EGM - December 13, 2023
Disclosure under Regulation 51
Intimation of EGM - December 13, 2023
Notice of Board Meeting - December 13, 2023
Disclosure under Regulation 57(1)
Newspaper publication of financial results for the quarter and half year ended September 30, 2023
Proceedings of EGM - November 02, 2023
Un-audited Financial Results for quarter and half year ended September 30, 2023
Outcome of Board Meeting- November 02, 2023
Intimation of EGM - November 02, 2023
Notice of Board Meeting - November 02, 2023
Intimation of Record Date
Disclosure under Regulation 51
Disclosure under Regulation 51
Reporting under SEBI Operational Circular for the half year ended September 30, 2023
Details of the RTA under Regulation 7(1) for the quarter ended September 30, 2023
Investor Grievance Report for the quarter ended September 30, 2023
Details of the CO under Regulation 6(1) for the quarter ended September 30, 2023
Proceedings of EGM - September 27, 2023
Disclosure under Regulation 51
Intimation of EGM - September 27, 2023
Notice of Board Meeting - September 27, 2023
Notice of Board Meeting - September 27, 2023
Compliance under Regulation 57(4) for the quarter ended December 31, 2023
Outcome of Board Meeting- September 18, 2023
Notice of Board Meeting - September 18, 2023
Newspaper publication of financial results for the period ended June 30, 2023
Un-audited Financial Results for quarter ended June 30, 2023
Outcome of Board Meeting-August 03, 2023
Notice of Board Meeting - August 03, 2023
Details of the RTA under Regulation 7(1) for the quarter ended June 30, 2023
Investor Grievance Report for the quarter ended June 30, 2023
Details of the CO under Regulation 6(1) for the quarter ended June 30, 2023
Compliance under Regulation 57(5) for the quarter ended June 30, 2023
Proceedings of 15th AGM- June 28, 2023
Compliance under Regulation 57(4) for the quarter ended September 30, 2023
Submission of Annual Report for the financial year ended March 31, 2023
Intimation of AGM- June 28, 2023
Notice of 15th Annual General Meeting
Newspaper publication of financial results for the period ended March 31, 2023
Audited Financial Results for the quarter & year ended March 31, 2023
Outcome of Board meeting –May 4, 2023
Notice of Board meeting – May 04, 2023
Reporting under Chapter XIV of SEBI Operational Circular
Initial Disclosure for the financial year ended March 31, 2023
Compliance under Regulation 57(5) for the quarter ended March 31, 2023
Certificate under Regulation 61(4) & 40(9) for the financial year ended March 31, 2023
Investor Grievance Report for the quarter ended March 31, 2023
Reporting under SEBI Operational Circular for the half year ended March 31, 2023
Details of the RTA under Regulation 7(1) for the quarter ended March 31, 2023
Details of the CO under Regulation 6(1) for the quarter ended March 31, 2023
Compliance under Regulation 57(5) for the quarter ended December 31, 2022
Compliance under Regulation 57(4) for the quarter ended March 31, 2023
Notice of Board Meeting - March 31, 2023
Disclosure under Regulation 57(1)
Intimation under Regulation 51(2)
Disclosure under Regulation 57(1)
Newspaper publication of financial results for the quarter and half year ended September 30, 2022
Disclosure under Regulation 54
Disclosure under Regulation 51(2) - November 3, 2022
Proceedings of the EGM - November 3, 2022
Intimation of EGM-November 3, 2022
Un-audited Financial Results for quarter and half year ended September 30, 2022
Outcome of Board Meeting-November 3, 2022
Notice of Board meeting – November 3, 2022
Investor Grievance Report for the quarter ended September 30, 2022
Intimation of Record date
Newspaper publication of financial results for the quarter and nine months' period ended December 31, 2022
Un-audited Financial Results for quarter ended December 31, 2022
Outcome of Board Meeting-February 9, 2023
Notice of Board Meeting- February 09, 2023
Investor Grievance Report for the quarter ended December 31, 2022
Details of the RTA under Regulation 7(1) for the quarter ended December 31, 2022
Disclosure under Regulation 55
Details of the CO under Regulation 6(1) for the quarter ended December 31, 2022
Details of CO & RTA for the quarter ended September 30, 2022
Compliance under Regulation 57(5) for the quarter ended September 30, 2022
Reporting under SEBI Operational Circular for the half year ended September 30, 2022
Notice of Board meeting - October 7, 2022
Compliance under Regulation 57(4) for the quarter ended December 31, 2022
Newspaper publication of financial results for the quarter ended June 30, 2022
Outcome of Board Meeting –August 10, 2022
Notice of Board meeting –August 10, 2022
Details of CO & RTA for the quarter ended June 30, 2022
Investor Grievance Report for the quarter ended June 30, 2022
Compliance under Regulation 57(5) for the quarter ended June 30 2022
Compliance under Regulation 57(4) for the quarter ended September 2022
Proceedings of the 14th AGM-June 9, 2022
Intimation of AGM-June 9, 2022
Submission of Annual Report for the financial year ended March 31, 2022
Statement of utilisation of proceeds as at March 31, 2022
Newspaper publication of financial results for the period ended March 31, 2022
Outcome of Board meeting –May 5, 2022
Security Cover as at March 31, 2022
Reporting under Chapter XIV of SEBI Operational Circular
Notice of Board meeting –May 5, 2022
Details of CO & RTA for the quarter ended March 31, 2022
Compliance Certificate for the financial year ended March 31, 2022
Certificate under Regulation 61(4) & 40(9) for the financial year ended March 31, 2022
Initial Disclosure for the financial year ended March 31, 2022
Investor Grievance Report for the quarter ended March 31, 2022
Reporting under SEBI Operational Circular for the half year ended March 31, 2022
Compliance under Regulation 57(5) for the quarter ended March 31 2022
Outcome of Board meeting –March 8, 2022
Notice of Board meeting –March 8, 2022
Details of CO & RTA for the quarter ended December 31, 2021
Newspaper publication of financial results for the quarter ended December 31, 2021
Statement of utilisation of proceeds as at December 31, 2021
Investor Grievance Report for the quarter ended December 31, 2021
Notice of Board meeting for the quarter ended December 31, 2021
Obligations for payment for the quarter ended December 31, 2021

Credit Rating

CREDIT RATING FOR SUBORDINATED DEBT :

Rating Agency Rating Rating Date
CARE Ratings Ltd. CARE A; Stable November 2, 2021
CARE Ratings Ltd. CARE A; Stable March 1, 2022
CARE Ratings Ltd. CARE A; Stable December 30, 2022
INVESTOR GRIEVANCE

All investor queries/complaints/grievances with respect to Debt Securities may be directed to: Mr. Rajat Sharma, Company Secretary at email Id: Secretarial@nivabupa.com

DEBENTURE TRUSTEE:

AXIS TRUSTEE SERVICES LIMITED
SEBI Registration Number: IND000000494
Registered Office: Axis House, Bombay Dyeing Mills Compound, Pandurang Budhkar Marg, Worli, Mumbai – 400025.
Corporate Office: The Ruby, 2nd Floor, SW, 29 Senapati Bapat Marg, Dadar West, Mumbai – 400028
Telephone: (022) 6230 0451 | Facsimile: +91-22-62300700
E-mail: debenturetrustee@axistrustee.in